News
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
3d
Amazon S3 on MSNPsoriasis Symptoms & TreatmentsDr. Jason Rivers, MD, FRCPC, discusses psoriasis symptoms and treatments.
Menthol is extracted from mint plants, creating a cooling sensation and providing temporary relief through counter-irritation ...
Biocon share rose after arm, Biocon Biologics, was granted market authorisation in the UK for Yesintek, a biosimilar of ...
8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.
4hOpinion
The Print on MSNYour lips need SPF too. There’s a risk of long-term damageSkincare products are yet to crack a one-size-fits-all formula, and the same stands for lip care as well, because as people, ...
Users call it “without a doubt the best sunscreen I have ever used ,” and “a must-have in my middle-aged skincare routine,” ...
Originating in Korea, “topical spicule products contain microscopic needle-like structures that gently penetrate the upper ...
With skincare trends popping up and fading away faster than Easter egg moments in films, this week I’m diving straight into neurocosmetics. This isn’t just a pa ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results